ANAB
Income statement / Annual
Last year (2024), AnaptysBio, Inc.'s total revenue was $91.28 M,
an increase of 432.03% from the previous year.
In 2024, AnaptysBio, Inc.'s net income was -$145.23 M.
See AnaptysBio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$91.28 M |
$17.16 M |
$10.29 M |
$63.18 M |
$75.00 M |
$8.00 M |
$5.00 M |
$10.00 M |
$16.68 M |
$17.57 M |
| Cost of Revenue |
$0.00
|
$2.38 M
|
$2.34 M
|
$98.50 M
|
$80.03 M
|
$99.34 M
|
$56.20 M
|
$29.44 M
|
$15.42 M
|
$17.30 M
|
| Gross Profit |
$91.28 M
|
$14.78 M
|
$7.95 M
|
-$35.32 M
|
-$5.03 M
|
-$91.34 M
|
-$51.20 M
|
-$19.44 M
|
$1.27 M
|
$267,000.00
|
| Gross Profit Ratio |
1
|
0.86
|
0.77
|
-0.56
|
-0.07
|
-11.42
|
-10.24
|
-1.94
|
0.08
|
0.02
|
| Research and Development Expenses |
$163.84 M
|
$132.28 M
|
$88.80 M
|
$98.50 M
|
$80.03 M
|
$99.34 M
|
$56.20 M
|
$29.44 M
|
$15.42 M
|
$17.30 M
|
| General & Administrative Expenses |
$42.39 M
|
$41.95 M
|
$36.64 M
|
$21.49 M
|
$18.85 M
|
$16.09 M
|
$15.53 M
|
$9.34 M
|
$4.29 M
|
$3.59 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$42.39 M
|
$41.95 M
|
$36.64 M
|
$21.49 M
|
$18.85 M
|
$16.09 M
|
$15.53 M
|
$9.34 M
|
$4.29 M
|
$3.59 M
|
| Other Expenses |
$0.00
|
$7.34 M
|
$12,000.00
|
$37,000.00
|
-$11,000.00
|
$1,000.00
|
-$159,000.00
|
$229,000.00
|
-$20,000.00
|
-$207,000.00
|
| Operating Expenses |
$206.23 M
|
$181.57 M
|
$125.44 M
|
$119.99 M
|
$98.88 M
|
$115.43 M
|
$71.72 M
|
$38.78 M
|
$19.71 M
|
$20.89 M
|
| Cost And Expenses |
$206.23 M
|
$181.57 M
|
$125.44 M
|
$119.99 M
|
$98.88 M
|
$115.43 M
|
$71.72 M
|
$38.78 M
|
$19.71 M
|
$20.89 M
|
| Interest Income |
$19.79 M
|
$18.87 M
|
$7.55 M
|
$431,000.00
|
$3.96 M
|
$10.98 M
|
$6.69 M
|
$1.62 M
|
$127,000.00
|
$18,000.00
|
| Interest Expense |
$50.09 M
|
$18.08 M
|
$21.11 M
|
$1.45 M
|
$0.00
|
$1.04 M
|
$1.65 M
|
$1.78 M
|
$458,000.00
|
$460,000.00
|
| Depreciation & Amortization |
$2.40 M
|
$2.38 M
|
$2.34 M
|
$2.09 M
|
$559,000.00
|
$514,000.00
|
$315,000.00
|
$183,000.00
|
$233,000.00
|
$274,000.00
|
| EBITDA |
-$92.74 M |
-$143.16 M |
-$105.26 M |
-$55.71 M |
-$19.37 M |
-$95.93 M |
-$59.88 M |
-$28.11 M |
-$3.57 M |
-$4.53 M |
| EBITDA Ratio |
-1.02
|
-8.34
|
-10.46
|
-0.89
|
-0.26
|
-12.06
|
-12.04
|
-2.69
|
-0.18
|
-0.19
|
| Operating Income Ratio |
-1.26
|
-9.58
|
-11.19
|
-0.9
|
-0.32
|
-13.43
|
-13.34
|
-2.88
|
-0.18
|
-0.19
|
| Total Other Income/Expenses Net |
-$30.28 M
|
$788,000.00
|
-$13.55 M
|
-$982,000.00
|
$3.95 M
|
$9.94 M
|
$4.87 M
|
-$1.29 M
|
-$1.23 M
|
-$1.94 M
|
| Income Before Tax |
-$145.23 M
|
-$163.62 M
|
-$128.70 M
|
-$57.80 M
|
-$19.93 M
|
-$97.49 M
|
-$61.85 M
|
-$30.07 M
|
-$4.26 M
|
-$5.27 M
|
| Income Before Tax Ratio |
-1.59
|
-9.54
|
-12.51
|
-0.91
|
-0.27
|
-12.19
|
-12.37
|
-3.01
|
-0.26
|
-0.3
|
| Income Tax Expense |
$3,000.00
|
-$4,000.00
|
$24,000.00
|
-$603,000.00
|
-$11,000.00
|
-$152,000.00
|
-$192,000.00
|
$1.82 M
|
$205,000.00
|
$139,000.00
|
| Net Income |
-$145.23 M
|
-$163.62 M
|
-$128.72 M
|
-$57.19 M
|
-$19.92 M
|
-$97.34 M
|
-$61.66 M
|
-$30.07 M
|
-$4.26 M
|
-$5.41 M
|
| Net Income Ratio |
-1.59
|
-9.54
|
-12.51
|
-0.91
|
-0.27
|
-12.17
|
-12.33
|
-3.01
|
-0.26
|
-0.31
|
| EPS |
-5.12 |
-6.08 |
-4.57 |
-2.08 |
-0.73 |
-3.6 |
-2.5 |
-1.52 |
-0.23 |
-0.38 |
| EPS Diluted |
-5.12 |
-6.08 |
-4.57 |
-2.08 |
-0.73 |
-3.6 |
-2.5 |
-1.52 |
-0.23 |
-0.36 |
| Weighted Average Shares Out |
$28.38 M
|
$26.92 M
|
$28.17 M
|
$27.43 M
|
$27.30 M
|
$27.06 M
|
$24.67 M
|
$19.78 M
|
$18.16 M
|
$14.15 M
|
| Weighted Average Shares Out Diluted |
$28.38 M
|
$26.92 M
|
$28.17 M
|
$27.43 M
|
$27.30 M
|
$27.06 M
|
$24.67 M
|
$19.78 M
|
$18.16 M
|
$14.99 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
